UNVERIFIEDSingle SourceSTAT+: Up and down the ladder: The latest comings and goingsStat News|2/13/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about Lilly bulking up on weight-loss drugs, scrutiny of a 340B contractor, and moreStat News|2/13/2026
UNVERIFIEDSingle SourceSTAT+: Trump administration is urged to use a federal law to authorize generic versions of GLP-1 drugsStat News|2/12/2026
UNVERIFIEDSingle SourceSTAT+: NIH redefines ‘clinical trials,’ dividing researchers Stat News|2/12/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about Sanofi replacing its CEO, MFN drug pricing opposed by conservatives, and moreStat News|2/12/2026
UNVERIFIEDSingle SourceSTAT+: Merck is urged by patient groups to ensure widespread access to an HIV prevention pill being testedStat News|2/11/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about FDA rejecting a Moderna vaccine, compounding in the crosshairs and moreStat News|2/11/2026
UNVERIFIEDSingle SourceSTAT+: Trump administration revives effort to launch pilot initiative reworking drug discount programStat News|2/10/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about FDA rejecting a rare disease drug, a warning to a Hims compounding pharmacy and moreStat News|2/10/2026
UNVERIFIEDSingle SourceSTAT+: OHSU board votes to negotiate with NIH and possibly transform its primate center into an animal sanctuaryStat News|2/9/2026
UNVERIFIEDSingle SourceSTAT+: FDA warned a Hims & Hers compounder after finding bugs and failing to report a serious side effectStat News|2/9/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about Novo Nordisk suing Hims & Hers, deals by Lilly and Takeda, and moreStat News|2/9/2026
UNVERIFIEDSingle SourceSTAT+: Lawsuit against Hims & Hers should be ‘wake-up call’ for compounders, Novo chief counsel saysStat News|2/9/2026
UNVERIFIEDSingle SourceSTAT+: Novo Nordisk sues Hims & Hers for infringing on a key Wegovy patentStat News|2/9/2026
UNVERIFIEDSingle SourceSTAT+: HHS asks Justice Department to probe Hims & Hers over its cheaper compounded version of WegovyStat News|2/7/2026
UNVERIFIEDSingle SourceSTAT+: Up and down the ladder: The latest comings and goingsStat News|2/6/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about TrumpRx, Hims & Hers selling compounded Wegovy pill, and moreStat News|2/6/2026
UNVERIFIEDSingle SourceSTAT+: Novo Nordisk accuses Hims & Hers of ‘illegal mass compounding’ over a cheaper version of Wegovy pillStat News|2/5/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about Super Bowl drug ads, an FTC deal with Express Scripts, and moreStat News|2/5/2026
UNVERIFIEDSingle SourceSTAT+: FTC settles lawsuit with Express Scripts over charges it manipulated insulin prices, impeded accessStat News|2/4/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about worries over FDA voucher program, a new U.S. Novo exec, and moreStat News|2/4/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about a Pfizer obesity pill, Florida’s failed drug importation plan, and moreStat News|2/3/2026
UNVERIFIEDSingle SourceSTAT+: As U.S. officials move to reduce animal testing in research, focus may shift to restrictions on importsStat News|2/3/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about obesity drug sales, India’s biopharma research push, and moreStat News|2/2/2026
UNVERIFIEDSingle SourceSTAT+: Sanofi is reprimanded by a U.K. trade group for misleading claims about a Pfizer vaccineStat News|2/2/2026
UNVERIFIEDSingle SourceSTAT+: Hospital group wants Trump administration to block a new Lilly policy on 340B claims dataStat News|1/26/2026
UNVERIFIEDSingle SourceSTAT+: Pharmalittle: We’re reading about pharma lobbying, an FDA gene-editing pathway, and moreStat News|1/26/2026